Advances in Understanding Lipodystrophy Syndromes: From Rare to Relevant
This activity is supported by educational funding provided by Chiesi.
Click Here to Manage Email Alerts
Overview
Launch Date: July 10, 2024
Expiration Date: July 10, 2025
Provider Statement
CME credit provided by the National Lipid Association
In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support Statement
This activity is supported by educational funding provided by Chiesi.
Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses, and registered dietitians with an interest in lipid management.
Learning Objectives
At the Conclusion of this activity, participants should be able to:
- Determine clinical diagnostic criteria to aid in the diagnosis of non-genetic lipodystrophy.
- Discuss the challenges of diagnosis and management of lipodystrophy.
- Evaluate the management of complex patients with rare lipid disorders through case discussions.
- Describe the mechanisms and manifestations of lipodystrophy.
- Identify treatment strategies for patients with lipodystrophy.
Faculty
Program Chair
Abhimanyu Garg, MD
Professor of Internal Medicine, Chief
Section of Nutrition and Metabolic Diseases, Division of Endocrinology
UT Southwestern Medical Center
Dallas, TX
Rebecca J Brown, MD, MHSc
Lasker Clinical Investigator
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Health
Vinaya Simha, MD
Associate Professor
Division of Endocrinology
Mayo Clinic
Rochester, MN
Krista Stevens
Patient Advocate
Reviewer
Kathleen H. Byrne, CRNP
Accreditation
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
CME credit provided by the National Lipid Association
In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Physician Assistants
NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME.
Pharmacists
Universal Activity Number – JA0007192-0000-24-023-H01-P (Application)
This Activity has been approved for 1.50 contact hour(s) (.150CEUs) of the Accreditation Council for Pharmacy Education.
Nursing
The maximum number of hours awarded for this CE activity is 1.50 contact hours.
Credit Designation
CME credit provided by the National Lipid Association
In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
How to Participate in this Activity and Obtain CME Credit
Statements of credit will be awarded based on the participant's completion and submission of the activity evaluation form. A statement of credit will be available for download upon completion of the online evaluation form. To receive credit, participants should complete the online course, score at least 30% on the post-test, and submit the evaluation. The deadline to claim credit is July 10, 2025.
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.
IMPORTANT* Pharmacists MUST request credit before (60 days from the last day to claim credit). Credit requested after this date will be subject to a fee by the accreditation board.Disclosures
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. Planners, faculty, reviewers, and staff have disclosed any financial relationships with commercial interests as defined by the ACCME. All disclosures have been reviewed and resolved at this time.
Faculty reports the following relationship(s)
Abhimanyu Garg, MD
Contracted Research – Amryt/Chiesi USA, Regeneron, Intercept
Consultant - Amryt/Chiesi USA, Arrowhead, Regeneron
Rebecca J Brown, MD, MHSc
Contracted Research- Regeneron, Amryt/Chiesi, Third Rock Ventures
Vinaya Simha, MD
Contracted Research – Amryt Pharmaceuticals
Krista Stevens
Nothing to disclose.
Reviewers report the following relationship(s)
NLA Staff reports no industry relationships.
Kathleen H. Byrne, CRNP reports no industry relationships.
Unlabeled and Investigational Usage
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Copyright Statement
The National Lipid Association acknowledges that permissions have been obtained for use of all copyrighted materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions have also been obtained from identifiable patients in photographs and other images, consistent with the DHHS HIPAA regulations for individual privacy.
CME Questions?
Questions about this CME activity may be sent to the National Lipid Association’s Continuing Medical Education Department at cme@lipid.org.